{"output": [["Celgene Corp.", "COMP", "Agree", "Buy", "ORG"], ["Celgene Corp.", "COMP", "Operate_In", "Pharmaceutical Industry", "SECTOR"], ["Celgene Corp.", "COMP", "Pay", "$1.1 Billion", "FIN_INSTRUMENT", "Upfront"], ["Impact Biomedicines", "ORG", "Receive", "$1.1 Billion", "FIN_INSTRUMENT", "Upfront"], ["Impact Biomedicines", "ORG", "Be", "Privately Held", "ORG"], ["Impact Biomedicines", "ORG", "Locate", "San Diego", "GPE"], ["Impact Biomedicines", "ORG", "Relate_To", "Blood-Disease Biotechnology"], ["Impact Biomedicines", "ORG", "Assume", "Hit Regulatory-Approval", "EVENT"], ["Impact Biomedicines", "ORG", "Potential", "Receive", "$7 Billion", "FIN_INSTRUMENT"]], "published": "2018-01-07T20:14:00.000+02:00"}